CFR › Title 21 › Part 329Part 329 — Nonprescription Human Drug Products Subject to Section 760 of the Federal Food, Drug, and Cosmetic Act§ 329.100— Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act.